Valtech Valuation Completes Valuation of a Medical Company
Valtech’s valuation team has recently completed valuation in relation to a transaction of a medical company. The target company’s business is to develop IVD diagnostics products for various diseases. We are engaged to conduct purchase price allocation (PPA) and valuation of an additional investment option.





